Impact News +++ RAM: Plastik- statt Pappverpackung soll vor Betrug schützen (Heise) +++ CORSAIR Aktie +4,30%

ELANCO Aktie

>ELANCO Aktienkurs

21.315 EUR +2.0% (TradegateBSX)

Ask: 21.23 EUR / 110 Stück

Bid: 21.12 EUR / 110 Stück

Tagesumsatz: 100 Stück

Realtime Kurs von 7:30 bis 22 Uhr!

ELANCO Aktie über LYNX handeln

Intraday

1 Jahr

>ELANCO Performance

1 Woche: +1,0%

1 Monat: +5,4%

3 Monate: +11,2%

6 Monate: +42,0%

1 Jahr: +92,7%

laufendes Jahr: +9,7%

>ELANCO Aktie

Name:

ELANCO ANIMAL HEALTH.

Land:

USA

Sektor:

Gesundheit

ISIN/ Wkn:

US28414H1032 / A2N6BH

Symbol/ Ticker:

5EA (Frankfurt) / ELAN (NYSE)

Kürzel:

FRA:5EA, ETR:5EA, 5EA:GR, NYSE:ELAN

Index:

Webseite:

https://www.elanco.com/

Profil:

Elanco Animal Health Incorporated is a leading global pharmaceutical company specializing in animal health. Its primary function is the development and delivery of innovative products and solutions to..
>Volltext..

Marktkapitalisierung:

10367.81 Mio. EUR

Unternehmenswert:

13370.25 Mio. EUR

Umsatz:

3858.16 Mio. EUR

EBITDA:

765.58 Mio. EUR

Nettogewinn:

30.25 Mio. EUR

Gewinn je Aktie:

0.06 EUR

Schulden:

3381.67 Mio. EUR

Liquide Mittel:

424.39 Mio. EUR

Operativer Cashflow:

528.6 Mio. EUR

Bargeldquote:

0.35

Umsatzwachstum:

-2.2%

Gewinnwachstum:

-83.34%

Dividende je Aktie:

Dividendenrendite:

Dividendenschätzung:

Insiderhandel:

Suchwörter:

ELANCO

Letzte Datenerhebung:

13.02.26

>ELANCO Kennzahlen

Aktien/ Unternehmen:

Aktien: 496.86 Mio. St.

Frei handelbar: 99.08%

Leerverk. Aktien: 4.68%

Rückkaufquote: -

Mitarbeiter: 9450

Umsatz/Mitarb.: 0.39 Mio. EUR

Analysten:

Analystenrating: Buy

Kursziel: 8.46%

Bewertung:

KGV: 330.87

KGV lG: 25.87

KUV: 2.7

KBV: 1.78

PEG-Ratio: -

EV/EBITDA: 17.46

Rentabilität:

Bruttomarge: 43.32%

Gewinnmarge: 0.78%

Operative Marge: 5.25%

Managementeffizenz:

Gesamtkaprendite: 0.27%

Eigenkaprendite: 0.54%

>ELANCO Peer Group

Gesundheit, Tiermedizin/ Tierbehandlung

>ELANCO Chart & Kurs - NYSE

>ELANCO News

13.02.26 - 16:12	Elanco board shrinks as two members opt out of reelection (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

13.02.26 - 15:27	Elanco Announces Updates to Board of Directors (PR Newswire)
	INDIANAPOLIS, Feb. 13, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) today announced updates to its Board of Directors. R. David Hoover and Deborah Kochevar will not stand for re-election at the conclusion of their terms at the 2026 Annual Meeting of Shareholders in......

30.01.26 - 16:42	Elanco: Protein, Science, Debate and Dietary Guidelines: Nina Teicholz (Accesswire)
	NORTHAMPTON, MA / ACCESS Newswire / January 30, 2026 / By Jeff SimmonsProtein. It's everywhere. From our center of the plate favorites to protein popcorn, ramen to even protein-packed ice cream, it......

22.01.26 - 17:15	Elanco upgraded, Zoetis downgraded at Piper Sandler (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

22.01.26 - 16:51	Piper Sandler upgrades Elanco as co gains traction with veterinary groups (Investing.com)
	Um den gesamten Artikel unter investing.com zu lesen, klicken Sie bitte auf die Überschrift...

22.01.26 - 14:01	Elanco Confirms Date and Conference Call for Fourth Quarter and Full Year 2025 Financial Results Announcement (PR Newswire)
	INDIANAPOLIS, Jan. 22, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will announce its fourth quarter and full year 2025 financial results on Tuesday, February 24, 2026. Elanco will also conduct a conference call on that day with the investment community and media to......

13.01.26 - 01:48

Stocks Rise as Credit Card Shares Slip on Trump Rate Cap Talk | The Close 1/12/2026 (Bloomberg)

Bloomberg Television brings you the latest news and analysis leading up to the final minutes and seconds before and after the closing bell on Wall Street. Today's guests are Former Federal Reserve Governor Betsy Duke, GE HealthCare's Peter Arduini, CFRA's Ken Leon, Zoetis' Kristin Peck, Morgan Stanley's Lauren Hochfelder, Blackrock's Jay Jacobs, Cornell University's Eswar Prasad, PGIM's Cathy Marcus, Elanco Animal Health's Jeff Simmons, Pfizer's Albert Bourla. (Source: Bloomberg)...

13.01.26 - 01:01	Elanco CEO: Gaining Market Share Via ′Major′ Innovations (Bloomberg)
	Jeff Simmons, Elanco Animal Health CEO, discusses pet-care growth with Katie Greifeld at the JPMorgan Healthcare Conference on “The Close.” He says the company is focused on pets, cattle and poultry. (Source: Bloomberg)...

06.01.26 - 14:03	Elanco to Participate in the 44th Annual J.P. Morgan Healthcare Conference (PR Newswire)
	INDIANAPOLIS, Jan. 6, 2026 /PRNewswire/ -- Elanco Animal Health Incorporated (NYSE: ELAN) will participate in the 44th Annual J.P. Morgan Healthcare Conference on Tuesday, January 13, 2026. Jeff Simmons, president and CEO, and Bob VanHimbergen, executive vice president and CFO, will......

01.01.26 - 07:18	Elanco Secures USDA Approval For Befrena, Expands Dermatology Portfolio (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health Inc. (ELAN) announced that the U.S. Department of Agriculture (USDA) has approved Befrena (tirnovetmab), a new anti-IL31 monoclonal antibody injection d......

31.12.25 - 20:33	Elanco gains approval of Befrena for canine dermatitis (SeekingAlpha)
	Um den gesamten Artikel unter seekingalpha.com zu lesen, klicken Sie bitte auf die Überschrift...

31.12.25 - 20:03	Elanco Receives USDA Approval for Befrena™ (tirnovetmab), a New Anti-IL31 Monoclonal Antibody Injection Targeting Canine Allergic and Atopic Dermatitis (PR Newswire)
	Elanco's second dermatology product approval in less than 18 months in the estimated $1.3 billion U.S. canine dermatology market Befrena has been shown to be effective for treatment of dogs of any age against canine atopic dermatitis and allergic dermatitis for 6 to 8 weeks of treatment,......

18.12.25 - 15:36	Elanco Receives FDA Conditional Approval For Credelio Quattro CA1 To Treat Screwworm In Dogs (AFX)
	WASHINGTON (dpa-AFX) - Elanco Animal Health Incorporated (ELAN) on Thursday said it has received conditional approval from the U.S. Food and Drug Administration (FDA) for Credelio Quattro CA1 for ......

18.12.25 - 14:45	Elanco′s Credelio Quattro™-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel chewable tablets) Receives First FDA Conditional Approval for Treatment of New World Screwworm in Dogs (PR Newswire)
	Conditional Approval Marks Elanco's Third New World Screwworm Treatment Option for Companion Animals, Providing Multiple Treatment Solutions Prior to Fly Being Detected in the U.S. FDA's Conditional Approval of Credelio Quattro-CA1 (lotilaner, moxidectin, praziquantel, and pyrantel......

18.12.25 - 14:42	Jim Cramer Praises Elanco Animal Health: ′They′ve Turned That Company Around′ (Benzinga)
	Cramer talks Elanco, Rocket Lab, Lithium Americas, Daktronics, M&T Bank and Ondas Holdings on the latest edition of Mad Money. read more...

17.12.25 - 15:45	Elanco Announces Investment in U.S. Manufacturing and R&D, Driven by Tax, Tariff and Regulatory Clarity (Accesswire)
	NORTHAMPTON, MA / ACCESS Newswire / December 17, 2025 / Elanco announced $400 million in continued investment in its U.S. operations, workforce and communities over the next five years. This deepen......

17.12.25 - 05:01	Insiderhandel: Aufsichtsrat kauft Aktien von Elanco Animal Health im Wert von 213000 USD (Insiderkauf)
	Kurzius, Lawrence Erik - Aufsichtsrat - Tag der Transaktion: 2025-12-12...

16.12.25 - 04:01	Insiderhandel: PRESIDENT, CEO AND DIRECTOR kauft Aktien von Elanco Animal Health im Wert von 478496 USD (Insiderkauf)
	Simmons, Jeffrey N. - Vorstand - Tag der Transaktion: 2025-12-11...

16.12.25 - 04:01	Insiderhandel: Vorstand kauft Aktien von Elanco Animal Health im Wert von 95985 USD (Insiderkauf)
	Modi, Rajeev A. - Vorstand - Tag der Transaktion: 2025-12-11...

16.12.25 - 04:01	Insiderhandel: EVP and CFO kauft Aktien von Elanco Animal Health im Wert von 150426 USD (Insiderkauf)
	Vanhimbergen, Robert M. - Vorstand - Tag der Transaktion: 2025-12-11...

>weitere News anzeigen...

>Impressum >Über uns >Datenschutz >Financial Data & Solutions

>Behalte deine Investments mit realtime Kursen & News im Blick. Finde neue spannende Aktien! Registriere Dich und werde Mitglied!

Zitat des Tages: Weiber lächeln, wenn sie grüßen. - Jean Paul

Partner: >TradegateBSX Börse | >Dukascopy | >TradingView | >Boersentreff- Partner

Börsentreff auf Facebook |

Börsentreff auf X |

Börsentreff auf Instagram